Voyager Therapeutics Inc (NASDAQ: VYGR) is -10.58% lower on its value in year-to-date trading and has touched a low of $4.99 and a high of $10.66 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VYGR stock was last observed hovering at around $5.06 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $5.07, the stock is -9.81% and -15.72% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.21 million and changing 0.20% at the moment leaves the stock -29.89% off its SMA200. VYGR registered -30.55% loss for a year compared to 6-month loss of -39.86%. The firm has a 50-day simple moving average (SMA 50) of $6.0156 and a 200-day simple moving average (SMA200) of $7.232.
The stock witnessed a -21.76% gain in the last 1 month and extending the period to 3 months gives it a -35.90%, and is -6.97% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.54% over the week and 5.24% over the month.
Voyager Therapeutics Inc (VYGR) has around 162 employees, a market worth around $276.95M and $163.78M in sales. Current P/E ratio is 7.03. Profit margin for the company is 15.80%. Distance from 52-week low is 1.60% and -52.44% from its 52-week high. The company has generated returns on investments over the last 12 months (7.02%).
with sales reaching $16.58M over the same period.The EPS is expected to shrink by -131.10% this year, but quarterly earnings will post -63.88% year-over-year. Quarterly sales are estimated to shrink -81.59% in year-over-year returns.
Voyager Therapeutics Inc (VYGR) Top Institutional Holders
180.0 institutions hold shares in Voyager Therapeutics Inc (VYGR), with institutional investors hold 78.77% of the company’s shares. The shares outstanding are 54.54M, and float is at 45.10M with Short Float at 5.46%. Institutions hold 65.54% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 5.31 million shares valued at $42.02 million. The investor’s holdings represent 9.3013% of the VYGR Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 5.2 million shares valued at $41.13 million to account for 9.1041 of the shares outstanding. The other top investors are ECOR1 CAPITAL, LLC which holds 3.92 million shares representing 6.8588% and valued at over $30.99 million, while VANGUARD GROUP INC holds 5.3199 of the shares totaling 3.04 million with a market value of $24.04 million.
Voyager Therapeutics Inc (VYGR) Insider Activity
The most recent transaction is an insider sale by Swartz Robin, the company’s COO & CBO. SEC filings show that Swartz Robin sold 3,087 shares of the company’s common stock on Jan 14 ’25 at a price of $5.09 per share for a total of $15713.0. Following the sale, the insider now owns 0.11 million shares.
Voyager Therapeutics Inc disclosed in a document filed with the SEC on Jan 14 ’25 that Carter Todd Alfred (Chief Scientific Officer) sold a total of 1,191 shares of the company’s common stock. The trade occurred on Jan 14 ’25 and was made at $5.13 per share for $6110.0. Following the transaction, the insider now directly holds 86436.0 shares of the VYGR stock.
Still, SEC filings show that on Jan 14 ’25, Swartz Robin (Officer) Proposed Sale 3,087 shares at an average price of $5.09 for $15721.0. The insider now directly holds shares of Voyager Therapeutics Inc (VYGR).
